The National Pharmaceutical Pricing Authority (NPPA) of India has capped the retail prices of 39 new drug formulations, including medications for BP, diabetes and heart disease.
Regulatory Action on Essential Medication Pricing
The Indian government, through the NPPA, regulates the cost of medicines.
According to the official notification issued by the NPPA, these price caps apply to various drug combinations used to treat high blood pressure, elevated blood sugar levels, and heart-related complications.
Scope of the Price Revisions
The recent announcement follows a broader trend of price adjustments by the NPPA. In addition to the 39 new formulations, the regulator has recently updated the ceiling prices for more than 30 drugs and biologics. Notably, the NPPA revised the ceiling price for Anti-Rabies Immunoglobulin Injection.
Impact on Healthcare Affordability
Frequently Asked Questions
What is the role of the NPPA?
How does the NPPA determine the price cap?
Are all medicines in India price-controlled?
Where can patients find the latest price list?